ライフサイエンスコーパス: cytokeratin-5

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ptor and ERBB2 expression, and expression of cytokeratin 5.

2 s, although none expressed the basal marker, cytokeratin 5.

3 e putative epithelial progenitor cell marker cytokeratin-5.

4 immunohistochemistry for basal cells using a cytokeratin 5/14 antibody; and immunohistochemistry for

5 ology and costain with the basal cell marker Cytokeratin 5/14, whereas the CD44(-) cancer cells resem

6 ell population also expressed the basal cell cytokeratins 5/14 and epidermal growth factor receptor.

7 pancytokeratin MNF116 (which reacts with the cytokeratins 5, 6, 8, 17, and probably 19), to PCK-26 (w

8 uclear hormone receptor and HER2 negativity, cytokeratin 5/6 and vimentin expression, and stem cell e

9 und that expression of cytokeratin 17 and/or cytokeratin 5/6 in tumor cells was associated with a poo

10 or PR+, HER2+), basal-like (ER-, PR-, HER2-, cytokeratin 5/6 positive, and/or HER1+), HER2+/ER- (ER-,

11 acterised by staining for basal markers (ie, cytokeratin 5/6).

12 c breast cancers expressing the basal marker cytokeratin 5/6, and age- and grade-matched controls, fo

13 n epidermal growth factor receptor 2 (HER2), cytokeratin 5/6, epidermal growth factor receptor, and K

14 , and "proliferation factor" (cytokeratin 5, cytokeratin 5/6, epidermal growth factor receptor, P53).

15 putative breast epithelial progenitor marker cytokeratin 5/6.

16 DP-153 cells express cytokeratins 5 and 14, but not cytokeratin 18, consisten

17 nitiating marker CD44, the progenitor marker cytokeratin 5 (CK5) and are more resistant to standard e

18 is positive for the early epithelial marker cytokeratin 5 (CK5) and the chemokine receptor CXCR4.

19 n of de-differentiated cell markers CD44 and cytokeratin 5 (CK5), lose luminal markers ER and PR, and

20 Cytokeratin 5 (CK5), which is expressed in both mammary

21 ve breast cancers contain a subpopulation of cytokeratin 5 (CK5)-expressing cells that are therapy re

22 uminal breast cancer, progesterone induces a cytokeratin-5 (CK5)-positive basal cell-like population.

23 a-negative cancer cells expressing the basal cytokeratin-5 (CK5).

24 roid sulfatase), and "proliferation factor" (cytokeratin 5, cytokeratin 5/6, epidermal growth factor

25 Donor-derived cytokeratin 5-expressing cells were rare, suggesting tha

26 Runx1, Runx3, and cytokeratin-5 expression increased significantly in rege

27 have discovered that a previously described cytokeratin 5 (K5)-Cre gene construct is expressed in ea

28 odel in which a ras oncogene is expressed in cytokeratin 5 (K5)-expressing cells on doxycycline admin

29 n of basal cells expressing Trp-63 (p63) and cytokeratins 5 (Krt5) and Krt14.

30 and the expression of cytokeratin 17 and/or cytokeratin 5 mRNAs.

31 ontain increased numbers of p63/AR-positive, cytokeratin 5-negative basal cells compared with WT or A

32 from an immature cytokeratin 5-positive to a cytokeratin 5-negative phenotype.

33 The tumors appear to arise from the cytokeratin 5-positive basal cell compartment.

34 lial cells fail to progress from an immature cytokeratin 5-positive to a cytokeratin 5-negative pheno

35 tch signalling to activate the DeltaNp63 and cytokeratin 5 program, and subsequent Notch blockade pro

36 ivate a DeltaNp63 (a p63 splice variant) and cytokeratin 5 remodelling program after influenza or ble

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。